Miss Pamela June Williams, MS, CCC-SLP | |
14 Chesley Dr, Barrington, NH 03825-3904 | |
(603) 664-2664 | |
(603) 664-5428 |
Full Name | Miss Pamela June Williams |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 14 Chesley Dr, Barrington, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669624045 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 1214 (New Hampshire) | Primary |
Mailing Address | Practice Location Address |
---|---|
Miss Pamela June Williams, MS, CCC-SLP 14 Chesley Dr, Barrington, NH 03825-3904 Ph: (603) 664-2664 | Miss Pamela June Williams, MS, CCC-SLP 14 Chesley Dr, Barrington, NH 03825-3904 Ph: (603) 664-2664 |
News Archive
YM BioSciences Inc., today reported that Pulmokine Inc. (Slingerlands, New York), a licensee of several small molecule compounds from YM, has been awarded two National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grants. The grants, totaling more than US$650,000, are Phase I awards to develop novel treatments for Pulmonary Arterial Hypertension (PAH).
Self-weighing can be a useful tool to help adults control their weight, but for adolescents and young adults this behavior may have negative psychological outcomes. Researchers from the University of Minnesota tracked the self-weighing behaviors of more than 1,900 young adults as part of Project EAT (Eating and Activity in Teens and Young Adults) and found increases in self-weighing to be significantly related to increases in weight concern and depression and decreases in body satisfaction and self-esteem among females.
Immune system cells are connected to each other by an extensive network of tiny tunnels that, like a building's hidden pneumatic tube system, are used to shoot signals to distant cells.
There is general agreement among hospital infection preventionists (IPs) with respect to which practices have weak or strong evidence supporting their use to prevent healthcare-associated infection, according to a new study published in the February issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Santarus, Inc., a specialty biopharmaceutical company, today announced the commercial U.S. launch of CYCLOSET (bromocriptine mesylate) tablets. CYCLOSET is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus both as monotherapy and in combination with other oral antidiabetic agents.
› Verified 8 days ago
Mrs. Jill Baker Dion, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 29 Spirit Ln, Barrington, NH 03825 Phone: 781-249-9996 | |
Mrs. Erica Leigh Hardy, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 194 Stagecoach Rd, Barrington, NH 03825 Phone: 508-335-7923 |